Men’s preferences for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia: a discrete choice experiment

References

• https://www.nice.org.uk/ [homepage on the internet]London: National Institute for Health and Clinical Excellence (NICE)NICE clinical guidelines: CG97. Lower urinary tract symptoms: The management of lower urinary tract symptoms in men [updated 2010] Available from: https://www.nice.org.uk/guidance/cg97/evidence/full-guideline-245363870Accessed August 19, 2015
   Google Scholar
• SextonCCCoyneKSKoppZSThe overlap of storage, voiding and postmicturition symptoms and implications for treatment seeking in the USA, UK and Sweden: EpiLUTSBJU Int2009103Suppl 3122319302498
   PubMed Web of Science ®Google Scholar
• PetersTJDonovanJLKayHEThe International Continence Society “benign prostatic hyperplasia” study: the botherosomeness of urinary symptomsJ Urol199715738858899072592
   PubMed Web of Science ®Google Scholar
• AbramsPMansonJKirbyMIncidence and epidemiology of storage lower urinary tract symptomsEur Urol Rev201275054
   Google Scholar
• GravasSBachmannADescazeaudAGuidelines on the management of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO)European Association of Urology [guidelines on the internet]2015 Available from: http://uroweb.org/wp-content/uploads/EAU-Guidelines-Non-Neurogenic-Male-LUTS-Guidelines-2015-v2.pdfAccessed August 19, 2015
   Google Scholar
• AuffenbergGBHelfandBTMcVaryKTEstablished medical therapy for benign prostatic hyperplasiaUrol Clin North Am2009364443459vvi19942044
   PubMed Web of Science ®Google Scholar
• RoehrbornCGBenign prostatic hyperplasia: an overviewRev Urol20057Suppl 9S3S14
   PubMedGoogle Scholar
• ChappleCRRoehrbornCGA shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladderEur Urol200649465165816530611
   PubMed Web of Science ®Google Scholar
• CoyneKSWeinAJTubaroAThe burden of lower urinary tract symptoms: evaluating the effect of LUTS on health-related quality of life, anxiety and depression: EpiLUTSBJU Int2009103Suppl 3411
   PubMed Web of Science ®Google Scholar
• SpeakmanMKirbyRDoyleSIoannouCBurden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) – focus on the UKBJU Int2015115450851924656222
   PubMed Web of Science ®Google Scholar
• RosenRAltweinJBoylePLower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7)Eur Urol200344663764914644114
   PubMed Web of Science ®Google Scholar
• WeinAJCoyneKSTubaroASextonCCKoppZSAiyerLPThe impact of lower urinary tract symptoms on male sexual health: EpiLUTSBJU Int2009103Suppl 33341
   Web of Science ®Google Scholar
• FourcadeROLacoinFRoupretMOutcomes and general health-related quality of life among patients medically treated in general daily practice for lower urinary tract symptoms due to benign prostatic hyperplasiaWorld J Urol201230341942621892656
   PubMed Web of Science ®Google Scholar
• OelkeMBachmannADescazeaudAEAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstructionEur Urol201364111814023541338
   PubMed Web of Science ®Google Scholar
• AningJJWassersugRJGoldenbergSLPatient preference and the impact of decision-making aids on prostate cancer treatment choices and post-intervention regretCurr Oncol201219Suppl 3S37S4423355792
   PubMed Web of Science ®Google Scholar
• EmbertonMMedical treatment of benign prostatic hyperplasia: physician and patient preferences and satisfactionInt J Clin Pract201064101425143520579137
   PubMed Web of Science ®Google Scholar
• ClarkMDDetermannDPetrouSMoroDde Bekker-GrobEWDiscrete choice experiments in health economics: a review of the literaturePharmacoeconomics201432988390225005924
   PubMed Web of Science ®Google Scholar
• http://www.fda.gov/ [homepage on the internet]Maryland: Food and Drug AdministrationGuidance for Industry and Food and Drug Administration Staff: Factors to Consider When Making Benefit-Risk Determinations in Medical Device Premarket Approval and De Novo Classifications [updated 2012 October 1] Available from: http://www.fda.gov/downloads/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/UCM296379.pdfAccessed August 19, 2015
   Google Scholar
• https://www.iqwig.de/ [homepage on the internet]Köln: Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)Allgemeine Methoden Version 4.1 [updated 2013] Available from: https://www.iqwig.de/download/IQWiG_General_Methods_Version_%204-1.pdfAccessed August 19, 2015
   Google Scholar
• http://www.ema.europa.eu/ema/ [homepage on the internet]London: European Medicines Agency; Road map to 2015The European Medicine’s Agency Contribution to Science, Medicines and Health [updated 2011] Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Report/2011/01/WC500101373.pdfAccessed August 19, 2015
   Google Scholar
• WatsonVRyanMBrownCTBarnettGEllisBWEmbertonMEliciting preferences for drug treatment of lower urinary tract symptoms associated with benign prostatic hyperplasiaJ Urol20041726 Pt 12321232515538258
   PubMed Web of Science ®Google Scholar
• Llewellyn-ThomasHAWilliamsJILevyLNaylorCDUsing a trade-off technique to assess patients’ treatment preferences for benign prostatic hyperplasiaMed Decis Making19961632622828818125
   PubMed Web of Science ®Google Scholar
• SwinburnPLloydAAliSHashmiNNewalDNajibHPreferences for antimuscarinic therapy for overactive bladderBJU Int2011108686887321105989
   PubMed Web of Science ®Google Scholar
• RyanMBateAEastmondCJLudbrookAUse of discrete choice experiments to elicit preferencesQual Health Care200110Suppl 1i55i6011533440
   PubMedGoogle Scholar
• CoastJAl-JanabiHSuttonEJUsing qualitative methods for attribute development for discrete choice experiments: issues and recommendationsHealth Econ201221673074121557381
   PubMed Web of Science ®Google Scholar
• RitchieJLewisJMcNaughton NichollsCOrmstonRQualitative Research Practice A Guide for Social Science Students and ResearchersLondonSAGE Publications Ltd2014
   Google Scholar
• LatiniJMMuellerELuxMMFitzgeraldMPKrederKJVoiding frequency in a sample of asymptomatic American menJ Urol2004172398098415311017
   PubMed Web of Science ®Google Scholar
• FitzgeraldMPBrubakerLVariability of 24-hour voiding diary variables among asymptomatic womenJ Urol2003169120720912478137
   PubMed Web of Science ®Google Scholar
• NotteSMMarshallTSLeeMContent validity and test-retest reliability of Patient Perception of Intensity of Urgency Scale (PPIUS) for overactive bladderBMC Urol2012122622958621
   PubMed Web of Science ®Google Scholar
• CartwrightRPanayiDCardozoLKhullarVReliability and normal ranges for the Patient’s Perception of Intensity of Urgency Scale in asymptomatic womenBJU Int2010105683283619818081
   PubMed Web of Science ®Google Scholar
• NaslundMJMinerMA review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostateClin Ther2007291172517379044
   PubMed Web of Science ®Google Scholar
• van DijkMMde la RosetteJJMichelMCEffects of alpha(1)-adrenoceptor antagonists on male sexual functionDrugs200666328730116526818
   PubMed Web of Science ®Google Scholar
• HollingsworthJMWiltTJLower urinary tract symptoms in menBMJ2014349g447425125424
   PubMed Web of Science ®Google Scholar
• OefeleinMGSafety and tolerability profiles of anticholinergic agents used for the treatment of overactive bladderDrug Saf201134973375421830836
   PubMed Web of Science ®Google Scholar
• EberthBWatsonVRyanMHughesJBarnettGDoes one size fit all? Investigating heterogeneity in men’s preferences for benign prostatic hyperplasia treatment using mixed logit analysisMed Decis Making200929670771519734440
   PubMed Web of Science ®Google Scholar
• KuhfeldWMarketing Research Methods in SAS: Experimental Design, Choice, Conjoint and Graphical TechniquesNorth CarolinaSAS Institute Inc2009
   Google Scholar
• HorneRWeinmanJHankinsMThe Beliefs about Medicines Questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medicationPsychol Health1999141124
   Web of Science ®Google Scholar
• TrainKDiscrete Choice Methods with SimulationNew YorkCambridge University Press2002
   Google Scholar
• OehlertGA note on the delta methodAm Stat19924612729
   Web of Science ®Google Scholar
• EmbertonMMarbergerMde la RosetteJUnderstanding patient and physician perceptions of benign prostatic hyperplasia in Europe: The Prostate Research on Behaviour and Education (PROBE) SurveyInt J Clin Pract2008621182618028388
   PubMed Web of Science ®Google Scholar
• KaplanSNaslundMPublic, patient, and professional attitudes towards the diagnosis and treatment of enlarged prostate: A landmark national US surveyInt J Clin Pract200660101157116516942587
   PubMed Web of Science ®Google Scholar
• EngstromGHenningsohnLWalker-EngstromMLLeppertJImpact on quality of life of different lower urinary tract symptoms in men measured by means of the SF 36 questionnaireScand J Urol Nephrol200640648549417130101
   PubMed Web of Science ®Google Scholar
• DjavanBLower urinary tract symptoms/benign prostatic hyperplasia: fast control of the patient’s quality of lifeUrology2003623 Suppl 161412957195
   PubMed Web of Science ®Google Scholar
• TangDHColaycoDPiercyJPatelVGlobeDChancellorMBImpact of urinary incontinence on health-related quality of life, daily activities, and healthcare resource utilization in patients with neurogenic detrusor overactivityBMC Neurol2014147424708598
   PubMed Web of Science ®Google Scholar
• DolderCRDutasteride: a dual 5-alpha reductase inhibitor for the treatment of symptomatic benign prostatic hyperplasiaAnn Pharmacother200640465866516569804
   PubMed Web of Science ®Google Scholar
• DutkiewicsSEfficacy and tolerability of drugs for treatment of benign prostatic hyperplasiaInt Urol Nephrol200132342343211583366
   PubMedGoogle Scholar
• MenniniFSGittoLMartellettiPImproving care through health economics analyses: cost of illness and headacheJ Headache Pain20089419920618604472
   PubMed Web of Science ®Google Scholar
• BronsteinAMGoldingJFGrestyMAThe social impact of dizziness in London and SienaJ Neurol2010257218319019701661
   PubMed Web of Science ®Google Scholar
• DeShazoJFermoGDesigning choice sets for stated preference methods: the effects of complexity on choice consistencyJ Environ Econ Manage2002441123143
   Web of Science ®Google Scholar
• MaddalaTPhillipsKAReed JohnsonFAn experiment on simplifying conjoint analysis designs for measuring preferencesHealth Econ200312121035104714673812
   PubMed Web of Science ®Google Scholar
• VineyRSavageELouviereJEmpirical investigation of experimental design properties of discrete choice experiments in health careHealth Econ200514434936215712274
   PubMed Web of Science ®Google Scholar
• AlemuMMorkbakMOlsenSJensenCAttending to the reasons for attribute non-attendance in choice experimentsEnviron Resour Econ2013543333359
   Web of Science ®Google Scholar
• https://www.ons.gov.uk/ [homepage on the internet]London: Office for National StatisticsInternet Access Quarterly Update, Q12014 [updated 2014 May 14] Available from: http://www.ons.gov.uk/ons/dcp171778_362910.pdfAccessed August 19, 2015
   Google Scholar